Related Experiment Video
Updated: Feb 15, 2026

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma
Manuel Weber1, Falk Wehrhan1, Christoph Baran1
1Department of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Background:
Immune checkpoints like programmed cell death-1 (PD-1) and its ligand PD-L1 are involved in immune escape mechanisms of solid tumors including oral squamous cell carcinoma (OSCC). Inhibitors of the pathway are successfully used for treating especially advanced disease. However, the physiological relevance of PD-1/PD-L1-signaling in OSCC is insufficiently understood. The aim of the study was to analyze if PD-L1 expression in tumor tissue and peripheral blood samples of OSCC patients is associated with histomorphological tumor parameters and if PD-L1 expression in patients is different from controls.
Results:
OSCC tumor specimens showed a significantly higher PD-L1 expression than oral mucosa controls (p < 0.001; upregulation more than 3-fold). Cross-tabulation revealed an association of increased expression of PD-L1 mRNA in tissue specimens with malignancy (p < 0.001).OSCC cases with higher tumor grade and cases with lymph node metastases (N+) were significantly (p < 0.05) associated with increased PD-L1 expression in peripheral blood. Cross-tabulation revealed an significant association with lymph node metastases (N+) (p ≤ 0.002).
Materials And Methods:
PD-L1 mRNA expression was analyzed in tumor specimens and corresponding samples of healthy oral mucosa and peripheral blood of 45 OSCC patients and 36 healthy control persons using RT-qPCR analysis. A Mann-Whitney U-test, a cut-off point analysis and a Chi-square test were carried out.
Conclusions:
PD-L1 expression in OSCC could contribute to the immunosuppressive local tumor microenvironment. Increased malignant behavior (higher tumor grade, positive nodal status) might be associated with PD-L1 mediated systemic immune tolerance. Thus, PD-L1 expression in peripheral blood might be an indicator of the existence of metastatic disease (N+) in OSCC.
Insights
Programmed cell death-1 ligand 1 (PD-L1) expression is elevated in oral squamous cell carcinoma (OSCC) and associated with malignancy. Increased PD-L1 in blood may indicate metastatic disease in OSCC patients.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Programmed cell death-1 (PD-1) and its ligand PD-L1 are key regulators of immune escape in solid tumors, including oral squamous cell carcinoma (OSCC).
- While PD-1/PD-L1 pathway inhibitors show efficacy in advanced cancers, their specific role in OSCC pathogenesis remains unclear.
- Understanding PD-L1 expression in OSCC is crucial for developing targeted immunotherapies.
Purpose of the Study:
- To investigate the association between PD-L1 expression in OSCC tumor tissue and peripheral blood with histomorphological tumor characteristics.
- To compare PD-L1 expression levels in OSCC patients versus healthy controls.
- To determine if PD-L1 expression can serve as a biomarker for disease progression in OSCC.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) was used to measure PD-L1 mRNA expression.
- Samples analyzed included tumor tissue, adjacent healthy oral mucosa, and peripheral blood from 45 OSCC patients and 36 controls.
- Statistical analyses included Mann-Whitney U-test, cut-off point analysis, and Chi-square test.
Main Results:
- OSCC tumor specimens exhibited significantly higher PD-L1 mRNA expression (over 3-fold upregulation) compared to oral mucosa controls (p < 0.001).
- Increased PD-L1 mRNA in tumor tissue correlated significantly with malignancy (p < 0.001).
- Higher tumor grade and lymph node metastasis (N+) in OSCC patients were significantly associated with elevated PD-L1 expression in peripheral blood (p < 0.05), with a strong association with nodal status (p ≤ 0.002).
Conclusions:
- PD-L1 expression in OSCC likely contributes to a local immunosuppressive tumor microenvironment.
- Elevated PD-L1 in OSCC correlates with increased malignancy, suggesting PD-L1-mediated systemic immune tolerance.
- PD-L1 expression in peripheral blood may serve as a valuable indicator of metastatic disease (N+) in OSCC patients.
More Related Videos
Related Concept Videos
Tissues
Cell Specific Gene Expression
Cell Specific Gene Expression
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...

